The Patent Finder

Biosynthema Inc.

Also on record
Records under this name other than patents Biosynthema Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Biosynthema Inc.

PatentTitleStatus Expires Confidence
US 8,293,873Combination of amino acid solution and a gelatin derivative for inhibiting renal up-take
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,122,622Peptide compounds having improved binding affinity to somatostatin receptors
Formerly held
Term ended
Term ended Dec 26, 2023 · From the USPTO record
Term endedTerm ended Dec 26, 2023From the USPTO record
US 7,202,330RGD (Arg-Gly-Asp) coupled to (neuro)peptides
Formerly held
Term ended
Term ended Dec 31, 2022 · From the USPTO record
Term endedTerm ended Dec 31, 2022From the USPTO record
US 6,664,367Stable analogs of bioactive peptides containing disulfide linkages
Formerly held
Term ended
Term ended Dec 16, 2020 · From the USPTO record
Term endedTerm ended Dec 16, 2020From the USPTO record
US 7,015,306Labeled neurotensin derivatives
Formerly held
Lapsed on the fee record
Ended Mar 21, 2018 · From the USPTO record
Lapsed on the fee recordEnded Mar 21, 2018From the USPTO record
US 5,310,536Ligands for improving metal chelate formation kinetics
Formerly held
Term ended
Term ended no later than May 10, 2014 · Low confidence
Term endedTerm ended no later than May 10, 2014Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited